165 related articles for article (PubMed ID: 37506364)
1. Type 1 Diabetes Genetic Risk Score Differentiates Subgroups of Ketosis-Prone Diabetes.
Osafehinti D; Mulukutla SN; Hampe CS; Gaba R; Ram N; Weedon MN; Oram RA; Balasubramanyam A
Diabetes Care; 2023 Oct; 46(10):1778-1782. PubMed ID: 37506364
[TBL] [Abstract][Full Text] [Related]
2. Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of "A-β+" ketosis-prone diabetes based on long-term β-cell function, human leukocyte antigen class II alleles, and sex predilection.
Nalini R; Ozer K; Maldonado M; Patel SG; Hampe CS; Guthikonda A; Villanueva J; O'Brian Smith E; Gaur LK; Balasubramanyam A
Metabolism; 2010 Oct; 59(10):1448-55. PubMed ID: 20170930
[TBL] [Abstract][Full Text] [Related]
3. Masked and overt autoantibodies specific to the DPD epitope of 65-kDa glutamate decarboxylase (GAD65-DPD) are associated with preserved β-cell functional reserve in ketosis-prone diabetes.
Oak S; Gaur LK; Radtke J; Patel R; Iyer D; Ram N; Gaba R; Balasubramanyam A; Hampe CS
J Clin Endocrinol Metab; 2014 Jun; 99(6):E1040-4. PubMed ID: 24601691
[TBL] [Abstract][Full Text] [Related]
4. SYNDROMES OF KETOSIS-PRONE DIABETES.
Balasubramanyam A
Trans Am Clin Climatol Assoc; 2019; 130():145-155. PubMed ID: 31516178
[TBL] [Abstract][Full Text] [Related]
5. Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes.
Brooks-Worrell BM; Iyer D; Coraza I; Hampe CS; Nalini R; Ozer K; Narla R; Palmer JP; Balasubramanyam A
Diabetes Care; 2013 Dec; 36(12):4098-103. PubMed ID: 24130366
[TBL] [Abstract][Full Text] [Related]
6. A-beta-subtype of ketosis-prone diabetes is not predominantly a monogenic diabetic syndrome.
Haaland WC; Scaduto DI; Maldonado MR; Mansouri DL; Nalini R; Iyer D; Patel S; Guthikonda A; Hampe CS; Balasubramanyam A; Metzker ML
Diabetes Care; 2009 May; 32(5):873-7. PubMed ID: 19228875
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics, beta-cell dysfunction and treatment outcomes in patients with A-β+ Ketosis-Prone Diabetes (KPD): The first identified cohort amongst Asian Indians.
Gupta RD; Ramachandran R; Gangadhara P; Anoop S; Singh SH; Satyaraddi A; Sathyakumar S; Asha HS; Thomas N
J Diabetes Complications; 2017 Sep; 31(9):1401-1407. PubMed ID: 28668376
[TBL] [Abstract][Full Text] [Related]
8. High Prevalence of
Kubota-Mishra E; Huang X; Minard CG; Astudillo M; Refaey A; Montes G; Sisley S; Ram N; Winter WE; Naylor RN; Balasubramanyam A; Redondo MJ; Tosur M;
Pediatr Diabetes; 2024; 2024():. PubMed ID: 38765897
[TBL] [Abstract][Full Text] [Related]
9. HLA class II alleles specify phenotypes of ketosis-prone diabetes.
Nalini R; Gaur LK; Maldonado M; Hampe CS; Rodriguez L; Garza G; Lernmark A; Balasubramanyam A
Diabetes Care; 2008 Jun; 31(6):1195-200. PubMed ID: 18316396
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Insulin Peptide-specific Interferon-γ-related Immune Responses in Ketosis-prone Type 2 Diabetes.
Satomura A; Oikawa Y; Haisa A; Suzuki S; Nakanishi S; Katsuki T; Shimada A
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2124-e2132. PubMed ID: 34922394
[TBL] [Abstract][Full Text] [Related]
11. Elevated unmethylated and methylated insulin DNA are unique markers of A+β+ ketosis prone diabetes.
Mulukutla SN; Tersey SA; Hampe CS; Mirmira RG; Balasubramanyam A
J Diabetes Complications; 2018 Feb; 32(2):193-195. PubMed ID: 29175121
[TBL] [Abstract][Full Text] [Related]
12. HLA class II alleles susceptibility markers of type 1 diabetes fail to specify phenotypes of ketosis-prone diabetes in adult Tunisian patients.
Laadhar L; Harzallah F; Zitouni M; Kallel-Sellami M; Fekih M; Kaabachi N; Slimane H; Makni S
Exp Diabetes Res; 2011; 2011():964160. PubMed ID: 21461382
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics Profiling of Patients With A-β+ Ketosis-Prone Diabetes During Diabetic Ketoacidosis.
Jahoor F; Hsu JW; Mehta PB; Keene KR; Gaba R; Mulukutla SN; Caducoy E; Peacock WF; Patel SG; Bennet R; Lernmark A; Balasubramanyam A
Diabetes; 2021 Aug; 70(8):1898-1909. PubMed ID: 34021044
[TBL] [Abstract][Full Text] [Related]
14. Evaluation and management of ketosis-prone diabetes.
Gaba R; Mehta P; Balasubramanyam A
Expert Rev Endocrinol Metab; 2019 Jan; 14(1):43-48. PubMed ID: 30612498
[TBL] [Abstract][Full Text] [Related]
15. THE CLINICAL AND METABOLIC CHARACTERISTICS OF YOUNG-ONSET KETOSIS-PRONE TYPE 2 DIABETES IN CHINA.
Zhang M; Li Y; Cui W; Yang P; Li H; Sheng C; Cheng X; Qu S
Endocr Pract; 2015 Dec; 21(12):1364-71. PubMed ID: 26372299
[TBL] [Abstract][Full Text] [Related]
16. Syndromes of ketosis-prone diabetes mellitus.
Balasubramanyam A; Nalini R; Hampe CS; Maldonado M
Endocr Rev; 2008 May; 29(3):292-302. PubMed ID: 18292467
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of patients with ketosis-prone diabetes (KPD) presenting with acute pancreatitis: implications for the natural history and etiology of a KPD subgroup.
Fernandez R; Misra R; Nalini R; Hampe CS; Ozer K; Balasubramanyam A
Endocr Pract; 2013; 19(2):243-51. PubMed ID: 23529349
[TBL] [Abstract][Full Text] [Related]
18. The first series of cases of ketosis-prone type 2 diabetes (flatbush diabetes) in Brazilian adults.
de Lima Ramaldes LA; Dos Santos SS; de Sa JR; Dualib PM; Dib SA
Arch Endocrinol Metab; 2021 Nov; 65(2):231-236. PubMed ID: 33905625
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of A⁻β⁺ ketosis-prone diabetes.
Patel SG; Hsu JW; Jahoor F; Coraza I; Bain JR; Stevens RD; Iyer D; Nalini R; Ozer K; Hampe CS; Newgard CB; Balasubramanyam A
Diabetes; 2013 Mar; 62(3):912-22. PubMed ID: 23160531
[TBL] [Abstract][Full Text] [Related]
20. Characterizing progressive beta-cell recovery after new-onset DKA in COVID-19 provoked A-β+ KPD (ketosis-prone diabetes): A prospective study from Eastern India.
Gupta RD; Atri A; Mondal S; Bhattacharjee A; Garai R; Hazra AK; Choudhury B; Dutta DS; Lodh M; Ganguly A
J Diabetes Complications; 2022 Mar; 36(3):108100. PubMed ID: 34916147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
